NextCure, Inc.
NXTC
$5.22
$0.0851.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.20M | 3.73M | 3.55M | 3.73M | 4.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.29M | 11.62M | 12.46M | 12.50M | 16.49M |
| Operating Income | -27.29M | -11.62M | -12.46M | -12.50M | -16.49M |
| Income Before Tax | -26.81M | -10.98M | -11.60M | -11.54M | -15.40M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.81M | -10.98M | -11.60M | -11.54M | -15.40M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.81M | -10.98M | -11.60M | -11.54M | -15.40M |
| EBIT | -27.29M | -11.62M | -12.46M | -12.50M | -16.49M |
| EBITDA | -26.66M | -10.97M | -11.78M | -11.80M | -15.79M |
| EPS Basic | -11.29 | -4.70 | -4.97 | -4.95 | -6.61 |
| Normalized Basic EPS | -7.06 | -2.94 | -3.11 | -3.09 | -4.13 |
| EPS Diluted | -11.29 | -4.70 | -4.97 | -4.95 | -6.61 |
| Normalized Diluted EPS | -7.06 | -2.94 | -3.11 | -3.09 | -4.13 |
| Average Basic Shares Outstanding | 2.37M | 2.33M | 2.33M | 2.33M | 2.33M |
| Average Diluted Shares Outstanding | 2.37M | 2.33M | 2.33M | 2.33M | 2.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |